Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Dimerix Ltd
DXBCurrent price
0.34 AUD
+0.027 AUD (+8.71%)
Last closed
0.32 AUD
Company
dimerix.com
ISIN
AU000000DXB7
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
193 725 455 AUD
Yield for 12 month
+60.48 %
1Y
3Y
5Y
10Y
15Y
DXB
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. The company develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 which is in phase 2 clinical trial for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. Dimerix Limited is headquartered in Fitzroy, Australia. Address: 425 Smith Street, Fitzroy, VIC, Australia, 3065
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.35 AUDP/E ratio
–Dividend Yield
–Current Year
+595 973 AUD
Last Year
+9 176 136 AUD
Current Quarter
+460 064 AUD
Last Quarter
+135 909 AUD
Current Year
+595 973 AUD
Last Year
+9 118 927 AUD
Current Quarter
+460 064 AUD
Last Quarter
+135 909 AUD
Key Figures DXB
1 year
3 years
5 years
10 years
EBITDA
-17 434 361 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-42.83 %
PEG Ratio
–
Return On Equity TTM
-141.42 %
Wall Street Target Price
1.35 AUD
Revenue TTM
595 974 AUD
Book Value
0.034 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
1 124.40 %
Dividend Yield
–
Gross Profit TTM
9 176 136 AUD
Earnings per share
-0.041 AUD
Diluted Eps TTM
-0.041 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics DXB
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History DXB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
24.09.1999
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
23.10.2017
Dividend Date
–
Stock Valuation DXB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
325.0569
Enterprise Value EBITDA
-1.9424
Price Book MRQ
10.5834
Financials DXB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DXB
For 52 weeks
0.16 AUD
0.68 AUD
50 Day MA
0.40 AUD
Shares Short Prior Month
–
200 Day MA
0.41 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart